Real-time enrollment status for this large b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 4:51 PM UTC
| NCT Number | NCT06610344 |
| Recruiting Status | Recruiting |
| Condition | Large B-cell Lymphoma |
| Phase | NA |
| Target Enrollment | 5 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Abramson Cancer Center at Penn Medicine |
| Last Updated on CT.gov | February 23, 2026 (Feb 23, 2026) |
As of July 19, 2026: Clinical trial NCT06610344 is currently recruiting participants. This na study for large b-cell lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Abramson Cancer Center at Penn Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06610344 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06610344 was last updated Feb 23, 2026 (February 23, 2026). HelloStudys verifies this status automatically.